학술논문
COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, June 2024, 204)
Subject
Language
English
ISSN
18790852
09598049
09598049